Global Artificial Pancreas Devices Systems Market Analysis and Forecast 2024-2030
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a 'closed-loop' system, an 'automated insulin delivery' system, or an 'autonomous system for glycemic control.'
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
According to APO Research, The global Artificial Pancreas Devices Systems market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
This report presents an overview of global market for Artificial Pancreas Devices Systems, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Artificial Pancreas Devices Systems, also provides the sales of main regions and countries. Of the upcoming market potential for Artificial Pancreas Devices Systems, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Artificial Pancreas Devices Systems sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Artificial Pancreas Devices Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Artificial Pancreas Devices Systems sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care and Defymed, etc.
Artificial Pancreas Devices Systems segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Pancreas Devices Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Pancreas Devices Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Pancreas Devices Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Artificial Pancreas Devices Systems in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Pancreas Devices Systems sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a 'closed-loop' system, an 'automated insulin delivery' system, or an 'autonomous system for glycemic control.'
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
According to APO Research, The global Artificial Pancreas Devices Systems market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
This report presents an overview of global market for Artificial Pancreas Devices Systems, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Artificial Pancreas Devices Systems, also provides the sales of main regions and countries. Of the upcoming market potential for Artificial Pancreas Devices Systems, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Artificial Pancreas Devices Systems sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Artificial Pancreas Devices Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Artificial Pancreas Devices Systems sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care and Defymed, etc.
Artificial Pancreas Devices Systems segment by Company
- Medtronic
- Bigfoot Biomedical
- Beta Bionics
- Admetsys
- Insulet
- Tandem Diabetes Care
- Defymed
- Threshold Suspended Device Systems
- Hybrid Closed-loop APDS
- Other Systems
- Hospitals
- Clinics
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Pancreas Devices Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Pancreas Devices Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Pancreas Devices Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Artificial Pancreas Devices Systems in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Pancreas Devices Systems sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Artificial Pancreas Devices Systems Market by Type
1.2.1 Global Artificial Pancreas Devices Systems Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Threshold Suspended Device Systems
1.2.3 Hybrid Closed-loop APDS
1.2.4 Other Systems
1.3 Artificial Pancreas Devices Systems Market by Application
1.3.1 Global Artificial Pancreas Devices Systems Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET DYNAMICS
2.1 Artificial Pancreas Devices Systems Industry Trends
2.2 Artificial Pancreas Devices Systems Industry Drivers
2.3 Artificial Pancreas Devices Systems Industry Opportunities and Challenges
2.4 Artificial Pancreas Devices Systems Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Artificial Pancreas Devices Systems Revenue Estimates and Forecasts (2019-2030)
3.2 Global Artificial Pancreas Devices Systems Revenue by Region
3.2.1 Global Artificial Pancreas Devices Systems Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Artificial Pancreas Devices Systems Revenue by Region (2019-2024)
3.2.3 Global Artificial Pancreas Devices Systems Revenue by Region (2025-2030)
3.2.4 Global Artificial Pancreas Devices Systems Revenue Market Share by Region (2019-2030)
3.3 Global Artificial Pancreas Devices Systems Sales Estimates and Forecasts 2019-2030
3.4 Global Artificial Pancreas Devices Systems Sales by Region
3.4.1 Global Artificial Pancreas Devices Systems Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Artificial Pancreas Devices Systems Sales by Region (2019-2024)
3.4.3 Global Artificial Pancreas Devices Systems Sales by Region (2025-2030)
3.4.4 Global Artificial Pancreas Devices Systems Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Artificial Pancreas Devices Systems Revenue by Manufacturers
4.1.1 Global Artificial Pancreas Devices Systems Revenue by Manufacturers (2019-2024)
4.1.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Artificial Pancreas Devices Systems Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Artificial Pancreas Devices Systems Sales by Manufacturers
4.2.1 Global Artificial Pancreas Devices Systems Sales by Manufacturers (2019-2024)
4.2.2 Global Artificial Pancreas Devices Systems Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Artificial Pancreas Devices Systems Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Artificial Pancreas Devices Systems Sales Price by Manufacturers (2019-2024)
4.4 Global Artificial Pancreas Devices Systems Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Artificial Pancreas Devices Systems Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Artificial Pancreas Devices Systems Manufacturers, Product Type & Application
4.7 Global Artificial Pancreas Devices Systems Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Artificial Pancreas Devices Systems Market CR5 and HHI
4.8.2 2023 Artificial Pancreas Devices Systems Tier 1, Tier 2, and Tier
5 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET BY TYPE
5.1 Global Artificial Pancreas Devices Systems Revenue by Type
5.1.1 Global Artificial Pancreas Devices Systems Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Artificial Pancreas Devices Systems Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Artificial Pancreas Devices Systems Revenue Market Share by Type (2019-2030)
5.2 Global Artificial Pancreas Devices Systems Sales by Type
5.2.1 Global Artificial Pancreas Devices Systems Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Artificial Pancreas Devices Systems Sales by Type (2019-2030) & (Units)
5.2.3 Global Artificial Pancreas Devices Systems Sales Market Share by Type (2019-2030)
5.3 Global Artificial Pancreas Devices Systems Price by Type
6 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET BY APPLICATION
6.1 Global Artificial Pancreas Devices Systems Revenue by Application
6.1.1 Global Artificial Pancreas Devices Systems Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Artificial Pancreas Devices Systems Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Artificial Pancreas Devices Systems Revenue Market Share by Application (2019-2030)
6.2 Global Artificial Pancreas Devices Systems Sales by Application
6.2.1 Global Artificial Pancreas Devices Systems Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Artificial Pancreas Devices Systems Sales by Application (2019-2030) & (Units)
6.2.3 Global Artificial Pancreas Devices Systems Sales Market Share by Application (2019-2030)
6.3 Global Artificial Pancreas Devices Systems Price by Application
7 COMPANY PROFILES
7.1 Medtronic
7.1.1 Medtronic Comapny Information
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Medtronic Artificial Pancreas Devices Systems Product Portfolio
7.1.5 Medtronic Recent Developments
7.2 Bigfoot Biomedical
7.2.1 Bigfoot Biomedical Comapny Information
7.2.2 Bigfoot Biomedical Business Overview
7.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Portfolio
7.2.5 Bigfoot Biomedical Recent Developments
7.3 Beta Bionics
7.3.1 Beta Bionics Comapny Information
7.3.2 Beta Bionics Business Overview
7.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Beta Bionics Artificial Pancreas Devices Systems Product Portfolio
7.3.5 Beta Bionics Recent Developments
7.4 Admetsys
7.4.1 Admetsys Comapny Information
7.4.2 Admetsys Business Overview
7.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Admetsys Artificial Pancreas Devices Systems Product Portfolio
7.4.5 Admetsys Recent Developments
7.5 Insulet
7.5.1 Insulet Comapny Information
7.5.2 Insulet Business Overview
7.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Insulet Artificial Pancreas Devices Systems Product Portfolio
7.5.5 Insulet Recent Developments
7.6 Tandem Diabetes Care
7.6.1 Tandem Diabetes Care Comapny Information
7.6.2 Tandem Diabetes Care Business Overview
7.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Portfolio
7.6.5 Tandem Diabetes Care Recent Developments
7.7 Defymed
7.7.1 Defymed Comapny Information
7.7.2 Defymed Business Overview
7.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Defymed Artificial Pancreas Devices Systems Product Portfolio
7.7.5 Defymed Recent Developments
8 NORTH AMERICA
8.1 North America Artificial Pancreas Devices Systems Market Size by Type
8.1.1 North America Artificial Pancreas Devices Systems Revenue by Type (2019-2030)
8.1.2 North America Artificial Pancreas Devices Systems Sales by Type (2019-2030)
8.1.3 North America Artificial Pancreas Devices Systems Price by Type (2019-2030)
8.2 North America Artificial Pancreas Devices Systems Market Size by Application
8.2.1 North America Artificial Pancreas Devices Systems Revenue by Application (2019-2030)
8.2.2 North America Artificial Pancreas Devices Systems Sales by Application (2019-2030)
8.2.3 North America Artificial Pancreas Devices Systems Price by Application (2019-2030)
8.3 North America Artificial Pancreas Devices Systems Market Size by Country
8.3.1 North America Artificial Pancreas Devices Systems Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Artificial Pancreas Devices Systems Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Artificial Pancreas Devices Systems Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Artificial Pancreas Devices Systems Market Size by Type
9.1.1 Europe Artificial Pancreas Devices Systems Revenue by Type (2019-2030)
9.1.2 Europe Artificial Pancreas Devices Systems Sales by Type (2019-2030)
9.1.3 Europe Artificial Pancreas Devices Systems Price by Type (2019-2030)
9.2 Europe Artificial Pancreas Devices Systems Market Size by Application
9.2.1 Europe Artificial Pancreas Devices Systems Revenue by Application (2019-2030)
9.2.2 Europe Artificial Pancreas Devices Systems Sales by Application (2019-2030)
9.2.3 Europe Artificial Pancreas Devices Systems Price by Application (2019-2030)
9.3 Europe Artificial Pancreas Devices Systems Market Size by Country
9.3.1 Europe Artificial Pancreas Devices Systems Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Artificial Pancreas Devices Systems Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Artificial Pancreas Devices Systems Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Artificial Pancreas Devices Systems Market Size by Type
10.1.1 China Artificial Pancreas Devices Systems Revenue by Type (2019-2030)
10.1.2 China Artificial Pancreas Devices Systems Sales by Type (2019-2030)
10.1.3 China Artificial Pancreas Devices Systems Price by Type (2019-2030)
10.2 China Artificial Pancreas Devices Systems Market Size by Application
10.2.1 China Artificial Pancreas Devices Systems Revenue by Application (2019-2030)
10.2.2 China Artificial Pancreas Devices Systems Sales by Application (2019-2030)
10.2.3 China Artificial Pancreas Devices Systems Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Artificial Pancreas Devices Systems Market Size by Type
11.1.1 Asia Artificial Pancreas Devices Systems Revenue by Type (2019-2030)
11.1.2 Asia Artificial Pancreas Devices Systems Sales by Type (2019-2030)
11.1.3 Asia Artificial Pancreas Devices Systems Price by Type (2019-2030)
11.2 Asia Artificial Pancreas Devices Systems Market Size by Application
11.2.1 Asia Artificial Pancreas Devices Systems Revenue by Application (2019-2030)
11.2.2 Asia Artificial Pancreas Devices Systems Sales by Application (2019-2030)
11.2.3 Asia Artificial Pancreas Devices Systems Price by Application (2019-2030)
11.3 Asia Artificial Pancreas Devices Systems Market Size by Country
11.3.1 Asia Artificial Pancreas Devices Systems Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Artificial Pancreas Devices Systems Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Artificial Pancreas Devices Systems Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Artificial Pancreas Devices Systems Market Size by Type
12.1.1 MEALA Artificial Pancreas Devices Systems Revenue by Type (2019-2030)
12.1.2 MEALA Artificial Pancreas Devices Systems Sales by Type (2019-2030)
12.1.3 MEALA Artificial Pancreas Devices Systems Price by Type (2019-2030)
12.2 MEALA Artificial Pancreas Devices Systems Market Size by Application
12.2.1 MEALA Artificial Pancreas Devices Systems Revenue by Application (2019-2030)
12.2.2 MEALA Artificial Pancreas Devices Systems Sales by Application (2019-2030)
12.2.3 MEALA Artificial Pancreas Devices Systems Price by Application (2019-2030)
12.3 MEALA Artificial Pancreas Devices Systems Market Size by Country
12.3.1 MEALA Artificial Pancreas Devices Systems Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Artificial Pancreas Devices Systems Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Artificial Pancreas Devices Systems Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Artificial Pancreas Devices Systems Value Chain Analysis
13.1.1 Artificial Pancreas Devices Systems Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Artificial Pancreas Devices Systems Production Mode & Process
13.2 Artificial Pancreas Devices Systems Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Artificial Pancreas Devices Systems Distributors
13.2.3 Artificial Pancreas Devices Systems Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Artificial Pancreas Devices Systems Market by Type
1.2.1 Global Artificial Pancreas Devices Systems Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Threshold Suspended Device Systems
1.2.3 Hybrid Closed-loop APDS
1.2.4 Other Systems
1.3 Artificial Pancreas Devices Systems Market by Application
1.3.1 Global Artificial Pancreas Devices Systems Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET DYNAMICS
2.1 Artificial Pancreas Devices Systems Industry Trends
2.2 Artificial Pancreas Devices Systems Industry Drivers
2.3 Artificial Pancreas Devices Systems Industry Opportunities and Challenges
2.4 Artificial Pancreas Devices Systems Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Artificial Pancreas Devices Systems Revenue Estimates and Forecasts (2019-2030)
3.2 Global Artificial Pancreas Devices Systems Revenue by Region
3.2.1 Global Artificial Pancreas Devices Systems Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Artificial Pancreas Devices Systems Revenue by Region (2019-2024)
3.2.3 Global Artificial Pancreas Devices Systems Revenue by Region (2025-2030)
3.2.4 Global Artificial Pancreas Devices Systems Revenue Market Share by Region (2019-2030)
3.3 Global Artificial Pancreas Devices Systems Sales Estimates and Forecasts 2019-2030
3.4 Global Artificial Pancreas Devices Systems Sales by Region
3.4.1 Global Artificial Pancreas Devices Systems Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Artificial Pancreas Devices Systems Sales by Region (2019-2024)
3.4.3 Global Artificial Pancreas Devices Systems Sales by Region (2025-2030)
3.4.4 Global Artificial Pancreas Devices Systems Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Artificial Pancreas Devices Systems Revenue by Manufacturers
4.1.1 Global Artificial Pancreas Devices Systems Revenue by Manufacturers (2019-2024)
4.1.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Artificial Pancreas Devices Systems Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Artificial Pancreas Devices Systems Sales by Manufacturers
4.2.1 Global Artificial Pancreas Devices Systems Sales by Manufacturers (2019-2024)
4.2.2 Global Artificial Pancreas Devices Systems Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Artificial Pancreas Devices Systems Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Artificial Pancreas Devices Systems Sales Price by Manufacturers (2019-2024)
4.4 Global Artificial Pancreas Devices Systems Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Artificial Pancreas Devices Systems Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Artificial Pancreas Devices Systems Manufacturers, Product Type & Application
4.7 Global Artificial Pancreas Devices Systems Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Artificial Pancreas Devices Systems Market CR5 and HHI
4.8.2 2023 Artificial Pancreas Devices Systems Tier 1, Tier 2, and Tier
5 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET BY TYPE
5.1 Global Artificial Pancreas Devices Systems Revenue by Type
5.1.1 Global Artificial Pancreas Devices Systems Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Artificial Pancreas Devices Systems Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Artificial Pancreas Devices Systems Revenue Market Share by Type (2019-2030)
5.2 Global Artificial Pancreas Devices Systems Sales by Type
5.2.1 Global Artificial Pancreas Devices Systems Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Artificial Pancreas Devices Systems Sales by Type (2019-2030) & (Units)
5.2.3 Global Artificial Pancreas Devices Systems Sales Market Share by Type (2019-2030)
5.3 Global Artificial Pancreas Devices Systems Price by Type
6 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET BY APPLICATION
6.1 Global Artificial Pancreas Devices Systems Revenue by Application
6.1.1 Global Artificial Pancreas Devices Systems Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Artificial Pancreas Devices Systems Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Artificial Pancreas Devices Systems Revenue Market Share by Application (2019-2030)
6.2 Global Artificial Pancreas Devices Systems Sales by Application
6.2.1 Global Artificial Pancreas Devices Systems Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Artificial Pancreas Devices Systems Sales by Application (2019-2030) & (Units)
6.2.3 Global Artificial Pancreas Devices Systems Sales Market Share by Application (2019-2030)
6.3 Global Artificial Pancreas Devices Systems Price by Application
7 COMPANY PROFILES
7.1 Medtronic
7.1.1 Medtronic Comapny Information
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Medtronic Artificial Pancreas Devices Systems Product Portfolio
7.1.5 Medtronic Recent Developments
7.2 Bigfoot Biomedical
7.2.1 Bigfoot Biomedical Comapny Information
7.2.2 Bigfoot Biomedical Business Overview
7.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Portfolio
7.2.5 Bigfoot Biomedical Recent Developments
7.3 Beta Bionics
7.3.1 Beta Bionics Comapny Information
7.3.2 Beta Bionics Business Overview
7.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Beta Bionics Artificial Pancreas Devices Systems Product Portfolio
7.3.5 Beta Bionics Recent Developments
7.4 Admetsys
7.4.1 Admetsys Comapny Information
7.4.2 Admetsys Business Overview
7.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Admetsys Artificial Pancreas Devices Systems Product Portfolio
7.4.5 Admetsys Recent Developments
7.5 Insulet
7.5.1 Insulet Comapny Information
7.5.2 Insulet Business Overview
7.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Insulet Artificial Pancreas Devices Systems Product Portfolio
7.5.5 Insulet Recent Developments
7.6 Tandem Diabetes Care
7.6.1 Tandem Diabetes Care Comapny Information
7.6.2 Tandem Diabetes Care Business Overview
7.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Portfolio
7.6.5 Tandem Diabetes Care Recent Developments
7.7 Defymed
7.7.1 Defymed Comapny Information
7.7.2 Defymed Business Overview
7.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Defymed Artificial Pancreas Devices Systems Product Portfolio
7.7.5 Defymed Recent Developments
8 NORTH AMERICA
8.1 North America Artificial Pancreas Devices Systems Market Size by Type
8.1.1 North America Artificial Pancreas Devices Systems Revenue by Type (2019-2030)
8.1.2 North America Artificial Pancreas Devices Systems Sales by Type (2019-2030)
8.1.3 North America Artificial Pancreas Devices Systems Price by Type (2019-2030)
8.2 North America Artificial Pancreas Devices Systems Market Size by Application
8.2.1 North America Artificial Pancreas Devices Systems Revenue by Application (2019-2030)
8.2.2 North America Artificial Pancreas Devices Systems Sales by Application (2019-2030)
8.2.3 North America Artificial Pancreas Devices Systems Price by Application (2019-2030)
8.3 North America Artificial Pancreas Devices Systems Market Size by Country
8.3.1 North America Artificial Pancreas Devices Systems Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Artificial Pancreas Devices Systems Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Artificial Pancreas Devices Systems Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Artificial Pancreas Devices Systems Market Size by Type
9.1.1 Europe Artificial Pancreas Devices Systems Revenue by Type (2019-2030)
9.1.2 Europe Artificial Pancreas Devices Systems Sales by Type (2019-2030)
9.1.3 Europe Artificial Pancreas Devices Systems Price by Type (2019-2030)
9.2 Europe Artificial Pancreas Devices Systems Market Size by Application
9.2.1 Europe Artificial Pancreas Devices Systems Revenue by Application (2019-2030)
9.2.2 Europe Artificial Pancreas Devices Systems Sales by Application (2019-2030)
9.2.3 Europe Artificial Pancreas Devices Systems Price by Application (2019-2030)
9.3 Europe Artificial Pancreas Devices Systems Market Size by Country
9.3.1 Europe Artificial Pancreas Devices Systems Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Artificial Pancreas Devices Systems Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Artificial Pancreas Devices Systems Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Artificial Pancreas Devices Systems Market Size by Type
10.1.1 China Artificial Pancreas Devices Systems Revenue by Type (2019-2030)
10.1.2 China Artificial Pancreas Devices Systems Sales by Type (2019-2030)
10.1.3 China Artificial Pancreas Devices Systems Price by Type (2019-2030)
10.2 China Artificial Pancreas Devices Systems Market Size by Application
10.2.1 China Artificial Pancreas Devices Systems Revenue by Application (2019-2030)
10.2.2 China Artificial Pancreas Devices Systems Sales by Application (2019-2030)
10.2.3 China Artificial Pancreas Devices Systems Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Artificial Pancreas Devices Systems Market Size by Type
11.1.1 Asia Artificial Pancreas Devices Systems Revenue by Type (2019-2030)
11.1.2 Asia Artificial Pancreas Devices Systems Sales by Type (2019-2030)
11.1.3 Asia Artificial Pancreas Devices Systems Price by Type (2019-2030)
11.2 Asia Artificial Pancreas Devices Systems Market Size by Application
11.2.1 Asia Artificial Pancreas Devices Systems Revenue by Application (2019-2030)
11.2.2 Asia Artificial Pancreas Devices Systems Sales by Application (2019-2030)
11.2.3 Asia Artificial Pancreas Devices Systems Price by Application (2019-2030)
11.3 Asia Artificial Pancreas Devices Systems Market Size by Country
11.3.1 Asia Artificial Pancreas Devices Systems Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Artificial Pancreas Devices Systems Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Artificial Pancreas Devices Systems Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Artificial Pancreas Devices Systems Market Size by Type
12.1.1 MEALA Artificial Pancreas Devices Systems Revenue by Type (2019-2030)
12.1.2 MEALA Artificial Pancreas Devices Systems Sales by Type (2019-2030)
12.1.3 MEALA Artificial Pancreas Devices Systems Price by Type (2019-2030)
12.2 MEALA Artificial Pancreas Devices Systems Market Size by Application
12.2.1 MEALA Artificial Pancreas Devices Systems Revenue by Application (2019-2030)
12.2.2 MEALA Artificial Pancreas Devices Systems Sales by Application (2019-2030)
12.2.3 MEALA Artificial Pancreas Devices Systems Price by Application (2019-2030)
12.3 MEALA Artificial Pancreas Devices Systems Market Size by Country
12.3.1 MEALA Artificial Pancreas Devices Systems Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Artificial Pancreas Devices Systems Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Artificial Pancreas Devices Systems Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Artificial Pancreas Devices Systems Value Chain Analysis
13.1.1 Artificial Pancreas Devices Systems Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Artificial Pancreas Devices Systems Production Mode & Process
13.2 Artificial Pancreas Devices Systems Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Artificial Pancreas Devices Systems Distributors
13.2.3 Artificial Pancreas Devices Systems Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
